Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;190(3):e154-e156.
doi: 10.1111/bjh.16981. Epub 2020 Jul 16.

Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery

Evangéline Clark  1 , Philippe Guilpain  2   3 , Ionut Laurentiu Filip  4 , Nathalie Pansu  4 , Clément Le Bihan  4 , Guillaume Cartron  5   6 , Emmanuelle Tchernonog  5 , Camille Roubille  7 , David Morquin  4 , Alain Makinson  4   8 , Edouard Tuaillon  9 , Vincent Le Moing  4
Affiliations
Comment

Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery

Evangéline Clark et al. Br J Haematol. 2020 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Fig 1
Fig 1
COVID‐19 clinical course of the patient following combined treatment with rituximab and bendamustine for lymphoma.
See this image and copyright information in PMC

Comment on

References

    1. Tepasse PR, Hafezi W, Lutz M, Kühn J, Wilms C, Wiewrodt R, et al. Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature. Br J Haematol. 2020. 10.1111/bjh.16896 - DOI - PMC - PubMed
    1. Avouac J, Airó P, Carlier N, Matucci‐Cerinic M, Allanore Y. Severe COVID‐19‐associated pneumonia in 3 patients with systemic sclerosis treated with rituximab. Ann Rheum Dis. 2020. 10.1136/annrheumdis-2020-217864 - DOI - PubMed
    1. Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria AT, et al. Rituximab for granulomatosis with polyangiitis in the pandemic of covid‐19: lessons from a case with severe pneumonia. Ann Rheum Dis. 2020. 10.1136/annrheumdis-2020-217549 - DOI - PubMed
    1. Guilpain P, Le Bihan C, Foulongne V, Taourel P, Pansu N, Maria AT, et al. Response to: ‘Severe COVID‐19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab’ by Avouac et al . Ann Rheum Dis. 2020. 10.1136/annrheumdis-2020-217955 - DOI - PubMed
    1. He X, Lau EH, Wu P, Deng X, Wang J, Hao X, et al. Temporal dynamics in viral shedding and transmissibility of COVID‐19. Nat Med. 2020;26:672–5. - PubMed